Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRoMPT BOLUS Pilot: LR vs NS in Pediatric Septic Shock
NCT03340805Phase 1Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jan 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lactated ringer's solution in septic shock (2 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Compliance With Study Fluid Administration in the Assigned Study Arm at 48 hours. Started Jan 2018; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03340805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340805.